EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells

Carmelina Antonella Iannuzzi iD, Iris Maria Forte iD, Marianna Tomeo, Anna Sfera, Francesco Pagano, Riziero Esposito Abate iD, Michelino De Laurentiis iD, Antonio Giordano, Luigi Alfano

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Carmelina Antonella Iannuzzi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, RNA-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Sbarro Health Research Organization, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) remains a leading cause of cancer-related mortality worldwide, with limited treatment options for triple-negative breast cancer (TNBC). The RNA-binding protein non-POU domain-containing octamer-binding protein (NONO) has emerged as a critical regulator of tumorigenesis, but its role in immune signaling remains unexplored. We analyzed the effect of NONO protein by modulating its expression using short hairpin RNA (shRNA) and a chemical inhibitor (R)-SKBG-1. We demonstrate that NONO depletion in MDA-MB-231 TNBC cells leads to cytoplasmic DNA accumulation, micronuclei formation, and activation of the cyclic GMP-AMP synthase—stimulator of interferon genes (cGAS/STING) pathway, resulting in enhanced modulation of the immune response. NONO-deficient cells showed increased cGAS and STING activation, Tank-binding kinase 1 (TBK1) phosphorylation, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) nuclear localization, and transcription of pro-inflammatory genes such as CC Motif Chemokine Ligand 5 (CCL5). These effects were recapitulated by pharmacological inhibition using (R)-SKBG-1, confirming NONO’s immunosuppressive function. Our findings establish NONO as a key modulator of immune activation in TNBC and suggest that its inhibition may enhance anti-tumor immunity. This work paves the way for potential combination strategies involving NONO inhibitors and immune checkpoint blockade, particularly in tumors with homologous recombination deficiencies or limited immune infiltration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsRNA-Binding ProteinsHumansCell Line, TumorFemaleSignal TransductionGene Expression Regulation, NeoplasticNucleotidyltransferasesNF-kappa BMembrane ProteinsProtein Serine-Threonine KinasesSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

NONO/p54cGAS/STINGcancer therapytriple-negative breast cancer

Substanzen

RNA-Binding ProteinsNucleotidyltransferasesNF-kappa BMembrane ProteinsProtein Serine-Threonine KinasesSTING1 protein, humanSTING ProteincGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseTBK1 protein, human

Autor:innen und Institutionen

  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.
  • Clinical and Translational Oncology Program, Scuola Superiore Meridionale (SSM, School of Advanced Studies), University of Naples Federico II, 80131 Naples, Italy.
  • Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Dipartimento di Salute Mentale, Fisica e Medicina Preventiva, Università degli Studi della Campania "Luigi Vanvitelli", 80122 Naples, Italy.
  • Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy.
  • Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.

ORCID-Profile: Carmelina Antonella Iannuzzi, Iris Maria Forte, Riziero Esposito Abate, Michelino De Laurentiis

Förderung

  • Ministero della Salute
  • Sbarro Health Research Organization
  • Italian Ministry of Health

Zitieren

APA

Iannuzzi, C. A., Forte, I. M., Tomeo, M., Sfera, A., Pagano, F., Esposito Abate, R., De Laurentiis, M., Giordano, A., & Alfano, L. (2025). NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178542

Vancouver

Iannuzzi CA, Forte IM, Tomeo M, Sfera A, Pagano F, Esposito Abate R, et al. NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178542

BibTeX
@article{Iannuzzi2025,
  author = {Iannuzzi, Carmelina Antonella and Forte, Iris Maria and Tomeo, Marianna and Sfera, Anna and Pagano, Francesco and Esposito Abate, Riziero and De Laurentiis, Michelino and Giordano, Antonio and Alfano, Luigi},
  title = {NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178542}
}
Kostenlos starten →